Lasagna A - Search Results

1

Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study.

Asperges E, Albi G, Zuccaro V, Sambo M, Pieri TC, Calia M, Colaneri M, Maiocchi L, Melazzini F, Lasagna A, Peri A, Mojoli F, Sacchi P, Bruno R. Asperges E, et al. Among authors: lasagna a. Infect Dis Ther. 2023 Jun;12(6):1625-1640. doi: 10.1007/s40121-023-00813-1. Epub 2023 May 17. Infect Dis Ther. 2023. PMID: 37198387 Free PMC article.

2

Lingual metastasis from renal cell carcinoma: a case report and literature review.

Ganini C, Lasagna A, Ferraris E, Gatti P, Paglino C, Imarisio I, Morbini P, Benazzo M, Porta C. Ganini C, et al. Among authors: lasagna a. Rare Tumors. 2012 Jun 26;4(3):e41. doi: 10.4081/rt.2012.e41. Epub 2012 Sep 4. Rare Tumors. 2012. PMID: 23087797 Free PMC article.

3

How to Use Prophylactic G-CSF in the Time of COVID-19.

Lasagna A, Zuccaro V, Ferraris E, Rizzo G, Tancredi RJ, Pedrazzoli P. Lasagna A, et al. JCO Oncol Pract. 2020 Nov;16(11):771-772. doi: 10.1200/OP.20.00484. Epub 2020 Sep 2. JCO Oncol Pract. 2020. PMID: 32877272 No abstract available.

4

COVID-19 and breast cancer: may the microbiome be the issue?

Lasagna A, Zuccaro V, Ferraris E, Corbella M, Bruno R, Pedrazzoli P. Lasagna A, et al. Future Oncol. 2021 Jan;17(2):123-126. doi: 10.2217/fon-2020-0764. Epub 2020 Nov 27. Future Oncol. 2021. PMID: 33244989 Free PMC article. No abstract available.

5

Risk of reactivation of occult hepatitis B during immunotherapy in cancer treatment: myth, reality or new horizons?

Lasagna A, Zuccaro V, Sacchi P, Chiellino S, Bruno R, Pedrazzoli P. Lasagna A, et al. Future Oncol. 2021 May;17(13):1577-1580. doi: 10.2217/fon-2020-1196. Epub 2021 Feb 16. Future Oncol. 2021. PMID: 33590770 No abstract available.

6

Bone metastases and hepatocellular carcinoma: some food for thought.

Lasagna A, Cuzzocrea F, Maccario G, Mahagna A, Sacchi P, U Mondelli M. Lasagna A, et al. Future Oncol. 2021 Oct;17(29):3777-3780. doi: 10.2217/fon-2021-0689. Epub 2021 Jul 27. Future Oncol. 2021. PMID: 34313153 No abstract available.

7

Infectious complications and immunotherapy: old pitfalls and new horizons.

Lasagna A, Cassaniti I, Sacchi P, Baldanti F, Bruno R, Pedrazzoli P. Lasagna A, et al. Future Oncol. 2022 Jul;18(22):2377-2381. doi: 10.2217/fon-2022-0277. Epub 2022 Jun 9. Future Oncol. 2022. PMID: 35678614 No abstract available.

8

Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report.

Lasagna A, Lenti MV, Cassaniti I, Sacchi P. Lasagna A, et al. Immunotherapy. 2022 Aug;14(12):915-925. doi: 10.2217/imt-2021-0342. Epub 2022 Jun 13. Immunotherapy. 2022. PMID: 35694999 Free PMC article.

9

Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir.

Lasagna A, Piralla A, Secondino S, Sacchi P, Baldanti F, Bruno R, Pedrazzoli P. Lasagna A, et al. Front Med (Lausanne). 2022 Jul 22;9:944855. doi: 10.3389/fmed.2022.944855. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35935759 Free PMC article.

10

Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment.

Lasagna A, Cassaniti I, Lilleri D, Quaccini M, Ferrari A, Sacchi P, Bruno R, Baldanti F, Pedrazzoli P. Lasagna A, et al. Front Med (Lausanne). 2022 Oct 26;9:1036473. doi: 10.3389/fmed.2022.1036473. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36388947 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters